Liproxstatin-1 - 97%, high purity , CAS No.950455-15-9

  • ≥97%
Item Number
L413818
Grouped product items
SKUSizeAvailabilityPrice Qty
L413818-5mg
5mg
In stock
$94.90
L413818-10mg
10mg
In stock
$165.90
L413818-25mg
25mg
In stock
$373.90
L413818-50mg
50mg
In stock
$699.90
L413818-100mg
100mg
In stock
$937.90

Ferroptosis Inhibitors

Basic Description

SynonymsN-[(3-chlorophenyl)methyl]-spiro[piperidine-4,2'(1'H)-quinoxalin]-3'-amine;N-[(3-chlorophenyl)methyl]spiro[4H-quinoxaline-3,4'-piperidine]-2-amine
Specifications & Purity≥97%
Biochemical and Physiological MechanismsLiproxstatin-1 is a potent inhibitor of iron death, a non apoptotic form of cell death characterized by iron dependent lethal accumulation of lipid reactive oxygen species (ROS). Liproxstatin-1 inhibited iron death in human cells and ischemia / reperfusio
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
Product Description

Information

Liproxstatin-1 Liproxstatin-1 is a potent ferroptosis inhibitor with an IC50 of 22 nM.


Targets

ferroptosis (Cell-free assay) 22 nM


In vitro

Liproxstatin-1 is able to inhibit ferroptosis in the low nanomolar range and inhibit the growth of Gpx4−/−cells with IC50 of 22 nM. Liproxstatin-1 (50 nM) completely prevents lipid peroxidation in Gpx4−/−cells. Liproxstatin-1 (200 nM) protects against FINs, such as BSO (10 µM), erastin (1 µM) and RSL3 (0.5 µM), in a dose dependent manner, whereas it fails to rescue cell death induced by staurosporine (0.2 µM) and H2O2 (200 µM).


In vivo

Liproxstatin-1 remarkably extends survival compared with the vehicle-treated group, delays ferroptosis in tubular cells, and mitigates tissue injury in ischaemia/reperfusion-induced liver injury.


Cell Research(from reference)

Cell lines:Gpx4−/−cells 

Concentrations:~200 nM 

Incubation Time:~72 h 

Product Properties

ALogP2.598
HBD Count3
Rotatable Bond3

Associated Targets(Human)

MRC5 (9203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Trypanosoma brucei brucei (13300 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Names and Identifiers

IUPAC Name N-[(3-chlorophenyl)methyl]spiro[1,4-dihydroquinoxaline-3,4'-piperidine]-2-imine
INCHI InChI=1S/C19H21ClN4/c20-15-5-3-4-14(12-15)13-22-18-19(8-10-21-11-9-19)24-17-7-2-1-6-16(17)23-18/h1-7,12,21,24H,8-11,13H2,(H,22,23)
InChi Key YAFQFNOUYXZVPZ-UHFFFAOYSA-N
Canonical SMILES C1CNCCC12C(=NCC3=CC(=CC=C3)Cl)NC4=CC=CC=C4N2
Isomeric SMILES C1CNCCC12C(=NCC3=CC(=CC=C3)Cl)NC4=CC=CC=C4N2
PubChem CID 135735917
Molecular Weight 340.85

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

14 results found

Lot NumberCertificate TypeDateItem
G2404031Certificate of AnalysisJul 20, 2023 L413818
H2307492Certificate of AnalysisJul 20, 2023 L413818
H2307499Certificate of AnalysisJul 20, 2023 L413818
H2307507Certificate of AnalysisJul 20, 2023 L413818
H2307509Certificate of AnalysisJul 20, 2023 L413818
H2307514Certificate of AnalysisJul 20, 2023 L413818
H2307519Certificate of AnalysisJul 20, 2023 L413818
H2307550Certificate of AnalysisJul 20, 2023 L413818
H2307552Certificate of AnalysisJul 20, 2023 L413818
H2307554Certificate of AnalysisJul 20, 2023 L413818
H2307555Certificate of AnalysisJul 20, 2023 L413818
G2229114Certificate of AnalysisJun 13, 2022 L413818
G2229115Certificate of AnalysisJun 13, 2022 L413818
G2229116Certificate of AnalysisJun 13, 2022 L413818

more

Chemical and Physical Properties

SolubilitySolubility (25°C) In vitro Ethanol: 4 mg/mL warmed with 50ºC Water: bath (11.73 mM); DMSO: Insoluble; Water: Insoluble;
DMSO(mg / mL) Max Solubility68
DMSO(mM) Max Solubility199.5012469
Water(mg / mL) Max Solubility<1

Related Documents

Solution Calculators